Home Your basket
• Vibrant Soundbridge middl...
   Price 10.50 €
• Type 1 tympanoplasties in...
   Price 12.00 €
• Vertigo and pathology of ...
   Price 10.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• When to suspect a perilym...
   Price 10.50 €
• Cochlear implant in elder...
   Price 10.50 €
• The effect of the speaker...
   Price 10.50 €
• Art and nose....
   Price 8.50 €
• Utility of positron emiss...
   Price 8.50 €
• Eustachian tube melanoma ...
   Price 8.50 €
• Vertigo: progress and pra...
   Price 8.50 €
• Bullet in the pharynx: En...
   Price 10.50 €
• A perceptual study of the...
   Price 8.50 €
• Fungal infections of para...
   Price 8.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Association of thyroid he...
   Price 12.50 €
• A study of consonant inte...
   Price 10.50 €
• The supracricoid laryngec...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Lengthening temporalis my...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Comparison between extern...
   Price 10.50 €
• Follow up of tracheostoma...
   Price 12.00 €
• Revascularized free scapu...
   Price 10.50 €
• Laryngeal paraganglioma m...
   Price 8.50 €
• Otomycosis: Clinical and ...
   Price 5.50 €
• Larynx manipulation....
   Price 5.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Ambulatory stapedectomy: ...
   Price 8.50 €
• "Sonorous man" - an appro...
   Price 8.50 €
• Endoscopic ligation of th...
   Price 12.00 €
• Management of cerebellopo...
   Price 10.50 €

Total Order 317.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2008 o

ONCOLOGY

Interest of the chest CT scanning in head and neck cancer


Authors : Dequanter D, Lothaire P, Lemort M, Canizares Perez A. C, Lalami Y, Awada AH. (Montigny le Tilleul)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,4:273-276.

Article published in french
Downloadable PDF document french



Summary : Introduction: The overall survival rate for patients with head and neck squamous cell carcinoma remains disappointingly static despite improved locoregional control. This has been attributed to the development of distant metastases and second primary malignancies in these patients, a large proportion of which occur in the thorax. The goal of this study is to determine the incidence of newly thoracic malignancies diagnosed initially and during the follow-up in head and neck patients by chest computed tomography. Methods: We retrospectively analysed the incidence of thoracic malignancies in 77 patients presented newly diagnosed cancer of the head and neck. Results: 15/77 patients were found to have thoracic malignancies. In 10/77 patients (14%) the diagnosis was made at the same time that the initial head and neck cancer. In 5/77 patients, the thoracic malignancies were diagnosed during the follow-up. In 3 of the 5 cases, the pulmonary lesion was diagnosed in patients with local recurrent tumours. The primary site or the stage had an effect on the incidence of simultaneous thoracic malignancies. Conclusion: The presence of distant metastases and second primary malignancies has major implications in the management and prognosis of patients presenting with head and neck carcinoma. We recommend a CT scanning of the thorax in the staging of patients presenting with head and neck cancer but also in the follow-up, particularly in patients with an advanced pharyngolaryngeal cancer.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE